✦ LIBER ✦

Stimulation of bacterial mutagenicity by inhibitors of mammalian cell multidrug resistance

✍ Scribed by Lynnette R. Ferguson; Pamela M. Turner; Bruce C. Baguley

Book ID: 113255544
Publisher: Elsevier Science
Year: 1991
Weight: 250 KB
Volume: 264
Category: Article
ISSN: 0165-7992
DOI: 10.1016/0165-7992(91)90084-h

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The basis of multidrug resistance in mam

The basis of multidrug resistance in mammalian cells: Homology with bacterial transport

✍ Ames, Glovanna Ferro-Luzzi 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 465 KB

Mammalian cell toxicity and bacterial mu

Mammalian cell toxicity and bacterial mutagenicity of nitrosoimidazoles

✍ William J. Ehlhardt; Bernard B. Beaulieu Jr.; Peter Goldman 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 374 KB

Multidrug resistance: Versatile drug sen

Multidrug resistance: Versatile drug sensors of bacterial cells

✍ Kim Lewis 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 92 KB

Preferential killing of multidrug-resist

Preferential killing of multidrug-resistant KB cells by inhibitors of glucosylceramide synthase

✍ Nicholson, K M; Quinn, D M; Kellett, G L; Warr, J R 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 209 KB

Amplification of P-glycoprotein genes in

Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines

✍ Riordan, John R.; Deuchars, Kathryn; Kartner, Norbert; Alon, Noa; Trent, Jeffrey 📂 Article 📅 1985 🏛 Nature Publishing Group 🌐 English ⚖ 435 KB

Susceptibility of multidrug resistance t

Susceptibility of multidrug resistance tumor cells to apoptosis induction by histone deacetylase inhibitors

✍ Maria D. Castro-Galache; Jose A. Ferragut; Victor M. Barbera; Elena Martín-Orozc 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 391 KB

The main goal of our study has been to analyze the efficiency of new anticancer drugs, specifically histone deacetylase inhibitors, in tumor cells bearing a multidrug resistance phenotype. We report that the histone deacetylase inhibitors, Trichostatin A and Suberoylanilide Hydroxamic Acid (SAHA), d